FindMyRecallSubscribe
Class III: unlikely to cause harmOngoing

Eugia US Lidocaine HCl Injection Recall

Lidocaine HCl Injection, USP 2%, 40 mg/2 mL (20 mg/mL), 2 mL per Single-Dose Vial, Rx O…

Eugia US LLC · East Windsor, NJ

Risk level
Class III
Reported by FDA
Jun 10, 2026
Recall ID
D-0552-2026
Check your lot numberHow we source this data

Summary

Eugia US recalled Lidocaine HCl Injection starting May 18, 2026. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0552-2026 on Jun 10, 2026. Reason: Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan. Status: Ongoing.

Why it was recalled

Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan

Product description

Lidocaine HCl Injection, USP 2%, 40 mg/2 mL (20 mg/mL), 2 mL per Single-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520. NDC: 55150-164-02

Lot numbers, UPCs & expiration codes

Lot, expiry: Lot 3LC26029A, exp Feb-2029; Lot 3LC26031A, exp Mar-2029

Where it was sold

US Nationwide.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0552-2026
Classification
Class III
Status
Ongoing
Recall initiated
May 18, 2026
FDA report date
Jun 10, 2026
Quantity
168,300 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Eugia US LLC

Original FDA data

Every field from FDA enforcement report D-0552-2026, exactly as published.

Show all FDA fields
City
East Windsor
State
NJ
Status
Ongoing
Country
United States
Event ID
99024
Address
279 Princeton Hightstown Rd
Code information
Lot, expiry: Lot 3LC26029A, exp Feb-2029; Lot 3LC26031A, exp Mar-2029
Postal code
08520-1401
Report date
Jun 10, 2026
Product type
Drugs
Recall number
D-0552-2026
Classification
Class III
Recalling firm
Eugia US LLC
Product quantity
168,300 vials
Reason for recall
Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan
Voluntary / mandated
Voluntary: Firm initiated
Product description
Lidocaine HCl Injection, USP 2%, 40 mg/2 mL (20 mg/mL), 2 mL per Single-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520. NDC: 55150-164-02
Distribution pattern
US Nationwide.
Recall initiation date
May 18, 2026
Initial firm notification
Letter
Center classification date
May 29, 2026

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0552-2026, published Jun 10, 2026. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls